Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathan M Lancaster

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Journal of Surgical Oncology|August 22, 2009
Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterationsNisha Bansal, William S Roberts, Sachin M Apte, et al.
Journal of Ovarian Research|April 30, 2021
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testingShelly Cummings, Susana San Roman, Jennifer Saam, et al.
Journal of Oncology Practice|January 14, 2017
Impact of Payer Constraints on Access to Genetic TestingPat Whitworth, Peter Beitsch, Christopher Arnell, et al.
Gynecologic Oncology|January 22, 2005
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancerRobyn A Sayer, Johnathan M Lancaster, Jennifer Pittman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survivalJohnathan M Lancaster, Robyn Sayer, Carrie Blanchette, et al.
Patient Education and Counseling|May 11, 2016
Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT healthGina Shetty, Julian A Sanchez, Johnathan M Lancaster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Gedunin, a novel natural substance, inhibits ovarian cancer cell proliferationSiddharth G Kamath, Ning Chen, Yin Xiong, et al.
American Journal of Obstetrics and Gynecology|May 1, 2004
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarraysAndrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2015
Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression DataReem Abdallah, Hye Sook Chon, Nadim Bou Zgheib, et al.
Breast Cancer Research and Treatment|September 12, 2020
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counselingGregory S Calip, John Kidd, Ryan Bernhisel, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Journal of Surgical Oncology|August 22, 2009
Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterationsNisha Bansal, William S Roberts, Sachin M Apte, et al.
Journal of Ovarian Research|April 30, 2021
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testingShelly Cummings, Susana San Roman, Jennifer Saam, et al.
Journal of Oncology Practice|January 14, 2017
Impact of Payer Constraints on Access to Genetic TestingPat Whitworth, Peter Beitsch, Christopher Arnell, et al.
Gynecologic Oncology|January 22, 2005
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancerRobyn A Sayer, Johnathan M Lancaster, Jennifer Pittman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survivalJohnathan M Lancaster, Robyn Sayer, Carrie Blanchette, et al.
Patient Education and Counseling|May 11, 2016
Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT healthGina Shetty, Julian A Sanchez, Johnathan M Lancaster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Gedunin, a novel natural substance, inhibits ovarian cancer cell proliferationSiddharth G Kamath, Ning Chen, Yin Xiong, et al.
American Journal of Obstetrics and Gynecology|May 1, 2004
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarraysAndrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2015
Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression DataReem Abdallah, Hye Sook Chon, Nadim Bou Zgheib, et al.
Breast Cancer Research and Treatment|September 12, 2020
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counselingGregory S Calip, John Kidd, Ryan Bernhisel, et al.
Pageof 8